Powder: -20°C for 3 years | In solvent: -80°C for 1 year
S26131 (N-[2-[7-[3-[8-(2-acetamidoethyl)naphthalen-2-yl]oxypropoxy]naphthalen-1-yl]ethyl]acetamide) behaves as an antagonist on MT1 and MT2 receptors with Ki of 0.5 and 112 nM respectively.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 31.00 | |
2 mg | In stock | $ 44.00 | |
5 mg | In stock | $ 72.00 | |
10 mg | In stock | $ 122.00 | |
25 mg | In stock | $ 196.00 | |
50 mg | In stock | $ 367.00 | |
100 mg | In stock | $ 543.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 79.00 |
Description | S26131 (N-[2-[7-[3-[8-(2-acetamidoethyl)naphthalen-2-yl]oxypropoxy]naphthalen-1-yl]ethyl]acetamide) behaves as an antagonist on MT1 and MT2 receptors with Ki of 0.5 and 112 nM respectively. |
Targets&IC50 | MT1:0.5 nM(Ki), MT2:112 nM(Ki) |
In vitro | S26131 is an effective and selective antagonist of MT1 and MT2 with KBs of 5.32 and 143 nM, respectively[1]. |
Synonyms | N-[2-[7-[3-[8-(2-acetamidoethyl)naphthalen-2-yl]oxypropoxy]naphthalen-1-yl]ethyl]acetamide |
Molecular Weight | 498.61 |
Formula | C31H34N2O4 |
CAS No. | 296280-56-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 25 mg/mL (50.14 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
S26131 296280-56-3 Neuroscience MT Receptor inhibit melatoninergic ligand MT2 antagonist selectively Melatonin Receptor N-[2-[7-[3-[8-(2-acetamidoethyl)naphthalen-2-yl]oxypropoxy]naphthalen-1-yl]ethyl]acetamide Inhibitor S 26131 S-26131 inhibitor